Study on ONC206 for Brain Tumors
This study is testing a new drug, ONC206, which may help stop brain tumors from growing. This drug is special because it can make cancer cells die without hurting normal cells. The study will also see if ONC206 is safe to use with or without radiation therapy. People who can join this study include children and young adults with certain types of brain tumors.
Key Points:
- Duration and Visits: The study lasts up to 24 months, with visits every 28 days for treatment.
- Eligibility: Patients must have specific types of brain tumors and meet certain health criteria.
- Risks and Benefits: The study will help determine if ONC206 is safe and effective, but there may be side effects.
If you or someone you know fits the criteria and is interested in participating, it is important to speak with the study team to understand the details and potential implications of joining the study.
How understandable was the trial content above?
Hard to understand
Easy to understand